SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Panacea Biotec Ltd

BSE: 531349 NSE: PANACEABIO ISIN: INE922B01023
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Panacea Biotec Ltd belong to?
Panacea Biotec Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Panacea Biotec Ltd a good quality company?
Panacea Biotec Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Panacea Biotec Ltd undervalued or overvalued?
Panacea Biotec Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Panacea Biotec Ltd a good buy now?
Panacea Biotec Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Panacea Biotec Ltd?
Panacea Biotec Ltd revenue growth is -13.8% for FY-2025 , which is below its 5 year CAGR of -8.8% , indicating slower growth.
Q.2 Gross Profit margin of Panacea Biotec Ltd?
Panacea Biotec Ltd Gross profit margin which is the profit after deduction of direct costs, is -1.9% for FY-2025 , which is in line with its 5 year median of -1.9% , indicating stable margins.
Q.3 Operating Profit Margin of Panacea Biotec Ltd?
Panacea Biotec Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -2.24% for FY-2025 , which is in line with its 5 year median of -2.24% indicating stable margins.
Q.4 Net Profit Margin of Panacea Biotec Ltd?
Panacea Biotec Ltd Net Profit Margin is -4.91% for FY-2025 , is in line with with its 5 year median of -4.91%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin -1.9 -1.9
Operating Profit Margin -2.24 -2.24
Net Profit Margin -4.91 -4.91
Q.5 Return on Asset of Panacea Biotec Ltd?
Panacea Biotec Ltd Return on Asset is -1.69%, which is in line with its 5 year historical median of -1.69%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Panacea Biotec Ltd?
Panacea Biotec Ltd Return on equity is -4.74% for FY-2025 , which is in line with its historical median of -4.74%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Panacea Biotec Ltd?
Panacea Biotec Ltd Return on capital employed is -2.13% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Panacea Biotec Ltd?
Panacea Biotec Ltd Cash conversion cycle is 14 days, below its historical median of 14 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.34 0.31
ROE -4.74 -4.74
ROCE -2.13 -2.13
Cash Conversion Cycle 14 days 14 days
Q.9 Debt to Equity ratio of Panacea Biotec Ltd?
Panacea Biotec Ltd Debt-to-Equity ratio is 0.73 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Panacea Biotec Ltd?
Panacea Biotec Ltd Debt to cash flow from operations is 57.97 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Panacea Biotec Ltd?
Promoters hold 72.48% of the Panacea Biotec Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Panacea Biotec Ltd vs industry peers?
Panacea Biotec Ltd revenue CAGR is -8.75% , compared to the industry median CAGR of 5.54% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 309.9 137.1
Gross Profit -5.9 15.1
Operating Profit -7 16
Net Profit -15 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.34 0.8
ROE -4.74 8.91
ROCE -2.13 11.59
Cash Conversion Cycle (days) 14.25 76

Valuation & price assessment

Q.1 Stock return of Panacea Biotec Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 14.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 14.4% 6.9% 43.5% -31.5%
Q.3 Valuation ratios of Panacea Biotec Ltd vs historical?
The current P/E is similar that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 0.00 40.28
Price to Book 7.6 0.00 2.77
Price to Sales 5.83 5.60 2.65
EV to EBITDA -132.58 0.00 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Eris Lifesciences
10. Piramal Pharma
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×